BIOGEN INC. Quarterly Other Assets, Noncurrent in USD from Q1 2010 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of noncurrent assets classified as other.
Summary
Biogen Inc. quarterly Other Assets, Noncurrent history and growth rate from Q1 2010 to Q3 2024.
  • Biogen Inc. Other Assets, Noncurrent for the quarter ending September 30, 2024 was $631M, a 16.3% decline year-over-year.
Other Assets, Noncurrent, Quarterly (USD)
Other Assets, Noncurrent, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 $631M -$123M -16.3% Sep 30, 2024 10-Q 2024-10-30
Q2 2024 $682M -$423M -38.3% Jun 30, 2024 10-Q 2024-08-01
Q1 2024 $698M -$683M -49.5% Mar 31, 2024 10-Q 2024-04-24
Q4 2023 $745M -$784M -51.3% Dec 31, 2023 10-Q 2024-10-30
Q3 2023 $755M -$858M -53.2% Sep 30, 2023 10-Q 2023-11-08
Q2 2023 $1.1B -$396M -26.4% Jun 30, 2023 10-Q 2023-07-25
Q1 2023 $1.38B -$387M -21.9% Mar 31, 2023 10-Q 2023-04-25
Q4 2022 $1.53B -$410M -21.2% Dec 31, 2022 10-K 2024-02-14
Q3 2022 $1.61B -$406M -20.1% Sep 30, 2022 10-Q 2022-10-25
Q2 2022 $1.5B -$1.03B -40.6% Jun 30, 2022 10-Q 2022-07-20
Q1 2022 $1.77B -$656M -27.1% Mar 31, 2022 10-Q 2022-05-03
Q4 2021 $1.94B -$960M -33.1% Dec 31, 2021 10-K 2023-02-15
Q3 2021 $2.02B +$184M +10% Sep 30, 2021 10-Q 2021-10-20
Q2 2021 $2.53B +$1.04B +70.4% Jun 30, 2021 10-Q 2021-07-22
Q1 2021 $2.42B +$1.29B +114% Mar 31, 2021 10-Q 2021-04-22
Q4 2020 $2.9B +$1.65B +131% Dec 31, 2020 10-K 2022-02-03
Q3 2020 $1.83B +$596M +48.1% Sep 30, 2020 10-Q 2020-10-21
Q2 2020 $1.48B +$177M +13.6% Jun 30, 2020 10-Q 2020-07-22
Q1 2020 $1.13B -$768M -40.4% Mar 31, 2020 10-Q 2020-04-23
Q4 2019 $1.25B -$438M -25.9% Dec 31, 2019 10-K 2021-02-03
Q3 2019 $1.24B +$229M +22.7% Sep 30, 2019 10-Q 2019-10-22
Q2 2019 $1.31B +$404M +44.8% Jun 30, 2019 10-Q 2019-07-24
Q1 2019 $1.9B +$1.52B +399% Mar 31, 2019 10-Q 2019-04-24
Q4 2018 $1.69B +$1.26B +292% Dec 31, 2018 10-K 2020-02-06
Q3 2018 $1.01B -$291M -22.3% Sep 30, 2018 10-Q 2018-10-23
Q2 2018 $902M -$366M -28.9% Jun 30, 2018 10-Q 2018-07-24
Q1 2018 $380M -$804M -67.9% Mar 31, 2018 10-Q 2018-04-24
Q4 2017 $432M -$904M -67.7% Dec 31, 2017 10-K 2019-02-06
Q3 2017 $1.3B +$60.8M +4.91% Sep 30, 2017 10-Q 2017-10-24
Q2 2017 $1.27B +$115M +10% Jun 30, 2017 10-Q 2017-07-25
Q1 2017 $1.18B +$89.9M +8.21% Mar 31, 2017 10-Q 2017-04-25
Q4 2016 $1.34B +$228M +20.6% Dec 31, 2016 10-K 2018-02-01
Q3 2016 $1.24B +$347M +38.9% Sep 30, 2016 10-Q 2016-10-26
Q2 2016 $1.15B +$401M +53.4% Jun 30, 2016 10-Q 2016-07-21
Q1 2016 $1.09B +$454M +70.9% Mar 31, 2016 10-Q 2016-04-21
Q4 2015 $1.11B +$353M +46.8% Dec 31, 2015 10-K 2017-02-02
Q3 2015 $892M +$327M +57.8% Sep 30, 2015 10-Q 2015-10-21
Q2 2015 $752M +$140M +22.9% Jun 30, 2015 10-Q 2015-07-24
Q1 2015 $641M +$1.36M +0.21% Mar 31, 2015 10-Q 2015-04-24
Q4 2014 $755M +$160M +27% Dec 31, 2014 10-K 2016-02-03
Q3 2014 $566M -$70.5M -11.1% Sep 30, 2014 10-Q 2014-10-22
Q2 2014 $612M +$77.9M +14.6% Jun 30, 2014 10-Q 2014-07-23
Q1 2014 $639M +$332M +108% Mar 31, 2014 10-Q 2014-04-23
Q4 2013 $594M +$320M +117% Dec 31, 2013 10-K 2015-02-04
Q3 2013 $636M +$365M +135% Sep 30, 2013 10-Q 2013-10-28
Q2 2013 $534M +$262M +96.4% Jun 30, 2013 10-Q 2013-07-25
Q1 2013 $307M -$62.1M -16.8% Mar 31, 2013 10-Q 2013-04-25
Q4 2012 $274M -$57.5M -17.3% Dec 31, 2012 10-K 2014-02-06
Q3 2012 $271M +$33.3M +14% Sep 30, 2012 10-Q 2012-10-25
Q2 2012 $272M +$60.1M +28.4% Jun 30, 2012 10-Q 2012-07-24
Q1 2012 $369M +$141M +61.7% Mar 31, 2012 10-Q 2012-05-01
Q4 2011 $332M +$83.4M +33.6% Dec 31, 2011 10-K 2013-02-05
Q3 2011 $238M +$30.6M +14.8% Sep 30, 2011 10-Q 2011-10-28
Q2 2011 $212M +$10M +4.97% Jun 30, 2011 10-Q 2011-07-26
Q1 2011 $228M +$17.3M +8.23% Mar 31, 2011 10-Q 2011-04-21
Q4 2010 $248M Dec 31, 2010 10-K 2012-02-03
Q3 2010 $207M Sep 30, 2010 10-Q 2010-10-26
Q2 2010 $202M Jun 30, 2010 10-Q 2010-07-20
Q1 2010 $211M Mar 31, 2010 10-Q 2010-04-20
* An asterisk sign (*) next to the value indicates that the value is likely invalid.